Heron Therapeutics (HRTX) FCF Margin (2010 - 2026)
Heron Therapeutics (HRTX) reported FCF Margin of 5.56% for Q1 2026, up 1752.0% on a YoY basis from 0.3% in Q1 2025, and up 75.41% quarter-over-quarter from 22.63% in Q4 2025.
Heron Therapeutics (HRTX) FCF Margin (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported FCF Margin for 12 years, with the latest figure at 5.56% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1752.0% year-over-year to 5.56%; the trailing twelve-month figure through Mar 2026 stood at 13.84% (up 169.0% YoY), and the FY2025 full-year result was 18.02%, down 122.0% from the prior year.
- FCF Margin for Q1 2026 stood at 5.56%, up from 22.63% in the prior quarter.
- The five-year high for FCF Margin was 8.96% in Q3 2024, with the low at 191.77% in Q1 2022.
- Historically, FCF Margin has averaged 52.8% across 5 years, with a median of 29.77% in 2025.
- Annual changes were most pronounced in 2022 — FCF Margin soared 17822 bps — and 2024, when it tumbled 3689 bps.
- Heron Therapeutics' FCF Margin stood at 126.38% in 2022, then jumped by 105 bps to 6.44% in 2023, then slumped by 573 bps to 30.45% in 2024, then advanced by 26 bps to 22.63% in 2025, then surged by 75 bps to 5.56% in 2026.
- The last three FCF Margin figures came in at 5.56% (Q1 2026), 22.63% (Q4 2025), and 3.48% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | -5.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.56% |
| Dec 31, 2025 | -22.63% |
| Sep 30, 2025 | 3.48% |
| Jun 30, 2025 | -29.77% |
| Mar 31, 2025 | -23.08% |
| Dec 31, 2024 | -30.45% |
| Sep 30, 2024 | 8.96% |
| Jun 30, 2024 | -12.78% |
| Mar 31, 2024 | -27.45% |
| Dec 31, 2023 | 6.44% |
| Sep 30, 2023 | -31.72% |
| Jun 30, 2023 | -86.40% |
| Mar 31, 2023 | -84.84% |
| Dec 31, 2022 | -126.38% |
| Sep 30, 2022 | -139.74% |
| Jun 30, 2022 | -103.85% |
| Mar 31, 2022 | -191.77% |
| Dec 31, 2021 | -221.00% |
| Sep 30, 2021 | -235.46% |
| Jun 30, 2021 | -282.08% |